Concord Medical Services Holdings Limited (NYSE:CCM – Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 30th, there was short interest totaling 2,167 shares, a decline of 68.2% from the October 15th total of 6,821 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average trading volume of 18,605 shares, the short-interest ratio is currently 0.1 days.
Analyst Ratings Changes
Several brokerages have recently issued reports on CCM. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Concord Medical Services in a research report on Friday, August 21st. Wall Street Zen upgraded Concord Medical Services to a “hold” rating in a research note on Saturday, August 15th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company has an average rating of “Sell”.
Concord Medical Services Stock Performance
Shares of CCM traded down $0.04 on Friday, reaching $3.51. 4,457 shares of the stock traded hands, compared to its average volume of 34,086. The stock’s 50-day moving average price is $3.68 and its 200-day moving average price is $4.16. Concord Medical Services has a 12 month low of $2.79 and a 12 month high of $6.80.
Concord Medical Services Company Profile
Concord Medical Services Holdings Limited was a China-based healthcare services company focused primarily on cancer treatment and diagnostic imaging. The company operated and managed medical facilities that provided radiotherapy, diagnostic imaging, and related oncology services, often through partnerships with hospitals and other healthcare institutions. Its business also included the provision of medical equipment, technology, and management services to healthcare providers. Concord Medical’s facilities and partnerships were concentrated in China, with a focus on expanding access to specialized cancer diagnosis and treatment in major cities and regional medical centers.
See Also
- Five stocks we like better than Concord Medical Services
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.
